The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The brain pacemaker market is experiencing significant growth, driven by various factors including the rising prevalence of neurological disorders and advancements in neuromodulation technologies. Here’s a closer look at what’s fueling this market expansion and the trends shaping its future.

Market Overview

• Current Market Size and Growth:
  • The brain pacemaker market grew from $1.37 billion in 2023 to $1.57 billion in 2024, reflecting a 15.1% CAGR.
  • This growth is largely attributed to the increasing prevalence of Parkinson’s disease, continuous improvements in neuromodulation technologies, and rising healthcare expenditure.
• Future Projections:
  • The market is expected to reach $2.77 billion by 2028, with a CAGR of 15.2%.
  • Key drivers include an aging population, expanded indications, and patient preference for non-pharmacological treatments.

Key Factors Driving Market Growth

• Prevalence of Neurological Disorders:
  • Neurological disorders, such as Parkinson’s and epilepsy, are becoming more common, especially as the global population ages.
  • Over 40% of the global population currently suffers from some form of neurological condition, a figure expected to nearly double by 2050.
• Advancements in Technology:
  • Continuous improvements in neuromodulation technologies are enhancing the efficacy and precision of brain pacemakers.
  • Innovations such as closed-loop DBS systems and wireless charging capabilities are setting new standards in patient care.
• Rising Awareness and Better Diagnostics:
  • Increased awareness and advancements in diagnostic techniques are leading to earlier detection and treatment of neurological conditions.
  • This is expanding the potential patient pool for brain pacemakers.

Innovations and Major Developments

• Medtronic’s Percept RC with BrainSense Technology:
  • Medtronic, a leader in the medical technology field, introduced the Percept RC DBS system featuring BrainSense technology in January 2024.
  • This system is the smallest and thinnest dual-channel neurostimulator, designed to capture and record brain signals in real-time.
  • The data collected allows healthcare providers to personalize and optimize DBS therapy, making it more effective for patients.
• Amber Therapeutics Acquires Bioinduction Limited:
  • In September 2023, Amber Therapeutics acquired Bioinduction Limited to become an integrated developer of closed-loop neuromodulation therapies.
  • This acquisition is expected to drive the development of advanced, intelligent neuromodulation devices, further boosting the market.

View More On The Brain Pacemaker Market Report 2024 – https://www.thebusinessresearchcompany.com/report/brain-pacemaker-global-market-report

Regional Insights

• North America:
  • North America was the largest region in the brain pacemaker market in 2023, benefiting from high healthcare expenditure and advanced medical infrastructure.
• Asia-Pacific:
  • Asia-Pacific is expected to be the fastest-growing region in the forecast period, driven by increasing healthcare access and a growing elderly population.

Conclusion

The brain pacemaker market is poised for robust growth in the coming years, driven by rising neurological conditions, technological advancements, and increased healthcare spending. Companies like Medtronic and Amber Therapeutics are leading the way with innovative products and strategic acquisitions, setting the stage for continued market expansion. As awareness of neurological disorders increases and diagnostic methods improve, the demand for brain pacemakers is expected to soar, offering new hope to millions of patients worldwide.

Request A Sample Of The Global Brain Pacemaker Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16634&type=smp